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Article Synopsis  
Community pharmacists are acknowledged as under-utilized, important and accessible health 
providers in providing harm reduction support to drug users via needle and syringe 
programmes (NSP). We conducted 30 interviews with pharmacists in order to understand and 
illustrate pharmacist experiences of providing NSP. In the main, pharmacist’s experiences 
illustrated the positive nature of providing NSP, and highlighted needs to develop harm 
reduction training for pharmacists and appropriate strategies to raise awareness, provide 
exchange packs to meet the specific needs of people who inject drugs and ensure the 
development of trusting relationships and opportunities to engage within a confidential service.  
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Abstract 
Background: Community pharmacists are increasingly acknowledged as under-utilized, 
important and accessible health providers in providing harm reduction support to drug users 
via needle and syringe programmes (NSP), provision of advice, HIV/Hepatitis testing and as 
referral mechanism to social, medical and treatment services. We report here on qualitative 
findings as part of the evaluation of the pilot Pharmacy Needle Exchange (PNEX) programme in 
Ireland.  
Objectives: The aim was to understand and illustrate pharmacist experiences of providing NSP. 
Methods: Of the 107 eligible pharmacies, a total of 70 participated in the national evaluation.  
Telephone interviews (n=17) and one-to-one interviews (n=13) using a semi-structured guide 
were conducted with 30 pharmacists. Analysis of data was conducted using the Empirical 
Phenomenological Psychological (EPP) five step protocol.  
Results: Pharmacist experiences illustrated the largely positive nature of providing NSP, and 
highlighted needs to develop harm reduction training for pharmacists and appropriate 
strategies to raise awareness, provide exchange packs to meet the specific needs of the diverse 
populations ofpeople who inject drugs and ensure the development of trusting relationships 
and opportunities to engage within a confidential service. 
Conclusions: Further enhancement of NSP coverage and targeted service delivery within 
national care pathways for drug and alcohol services is warranted. 
 
Key Words 
Needle and syringe programme, opiate users, injecting drug users, harm reduction 
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Introduction 
Community pharmacists are increasingly acknowledged as under-utilized, important and 
accessible health providers to drug users, including people who inject drugs (PWID), and most 
particularly in combatting the transmission of HIV and other blood-borne virus (BBV) 
infection.1,2 A mix of needle and syringe programme (NSP) models such as fixed location, 
mobile/outreach and community pharmacy based can optimize service user access to harm 
reduction services.3-5 Given their unique and accessible position in the community, pharmacists 
and pharmacy staff are ideally positioned to reach PWID, who are covert, have concerns around 
anonymity and who become “more visible” when accessing community service settings such as 
pharmacies.1,6 The advantages of community pharmacy based NSP include longer opening 
hours, convenience, contact with health professionals, ability to engage with small numbers of 
service users in one place, and facilitate referral onto addiction and other medical services.7 
Harm reduction roles for community pharmacists include the provision of injecting equipment, 
dispensing methadone for treatment of opiate dependents and sale/supply of condoms. NSP 
provided in community pharmacies demonstrate considerable benefits for PWID and the 
public.8,9 NSP initiation is reported to be inversely associated with obtaining syringes at 
pharmacies and reporting needle sharing.10 Convenience, reduced stigma and anonymity for 
PWID in accessing sterile  injecting equipment, onsite HIV and Hepatitis C testing in pharmacies, 
provision of harm reduction advice, referrals to social (housing and eligibility assistance) and 
medical services, and entry and retention in detoxification programmes are also reported.1,11-17 
Other studies report reduced heroin use, criminal activity, and HIV infection rates, and the 
positive engagement with social drug users vulnerable to developing high risk behaviours.18-20 
Marked declines in the incidence of HCV infection are reported where targeted risk reduction 
efforts for the prevention of HIV were implemented.21 There is currently limited evidence 
regarding the pharmacy as a setting for BBV services, however in the UK dry blood spot testing 
for HCV in the pharmacy has been successfully offered in the pharmacy and linked into 
vaccination, referral and treatment pathways.22 In the United Kingdom, NICE guidance 
recommends the commissioning of integrated care pathways for PWID.23 Community 
pharmacy-based NSP complement fixed and outreach based models as they facilitate access to 
different populations of injecting drug users.3,7 More recently in 2015/2016, emergent trends in 
injecting of performance and image enhancement drugs and new psychoactive substances 
warrant continued provision of harm reduction services in community pharmacy.24  
 
It is important to understand the experiences of pharmacists providing the service to ensure 
continued engagement and effective service provision for those already accessing services, 
whilst also increasing access for other PWID not currently engaging. Matheson et al.25 in their 
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study in Scotland reported how addressing negative attitudes could encourage greater 
pharmacy participation in provision of NSP services, and also enhance the service delivery itself. 
In a later study, Matheson et al.14,26 also described how increased exposure to PWID can 
stimulate positive attitude change, and how changes in pharmacy practices can enhance 
provision efficiency in terms of pharmacist laying down of ground rules with service users, 
requiring identification, pre-prepared packs, and providing verbal advice and leaflets around 
harm reduction. Their studies also noted a doubling in uptake of drug misuse training following 
implementation of the service. Matheson et al reported in 201627 that pharmacy workforce 
attitudes and service user engagement with the needle exchange process could further improve 
over time, and do require greater embedding within addiction teams.  
 
NSP services were first provided in Ireland in 1989 in the former Eastern Health Board AIDS 
Resource Centre in Dublin, in response to the heroin problem in the capital at the time.7 Ireland 
reports the highest rate of heroin use in Europe with just over 7 cases per 1000 population.28 
Most recent National Drug Treatment Reporting System (NTDRS) data estimates that there are 
between 18,136 and 23,576 opioid users resident in Ireland.28 Small increases were evident in 
numbers reporting opioids as primary and secondary problematic drug, with increases most 
notable in the older drug using population.29 Opioid use prevalence among Irish females has 
increased since 2001.28  Irish Focal Point data for 2012 indicated that 3,971 of those entering 
treatment reported opioids, mainly heroin as their primary problem drug, with 45% reporting 
injecting use. In 2012 injecting drug use (IDU) accounted for 76% of all Hepatitis C virus 
diagnoses.   
 
The National Drugs Strategy 2009 – 2016 has highlighted the limited availability of NSP services 
in five of the 10 Regional Drug Task Forces and in 13 out of 14 Local Drug Task Forces.30 The 
national Pharmacy Needle Exchange (PNEX) programme commenced in 2011. The PNEX 
Programme is a partnership initiative between the Elton John Aids Foundation, Irish Pharmacy 
Union and the Health Service Executive (HSE). The development and implementation of the 
PNEX Programme was closely aligned with Action 34 of the National Drug Strategy 2009-2016 
to “expand the availability of, and access to needle exchange services (where required)”.  The 
aim of PNEX Programme was to increase access to needle and syringe exchange for people who 
inject drugs, and more broadly to reduce the risk of HIV and other blood borne viruses in 
Ireland by rolling out provision of needle exchange services within pharmacies.7  Prior to the 
PNEX, NSP services were mainly located in the east of Ireland, and provided by statutory and 
voluntary agencies funded by the Health Service Executive (HSE). The PNEX programme covers 
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all areas outside of Co. Dublin, Co. Wicklow and Co. Kildare. Its specific aims cited directly from 
the recent review of needle exchange provision in Ireland by Bingham et al.7 (p8) are as follows; 
 
1. Prevent the spread of HIV and Hepatitis C through reducing their transmission by providing 
sterile injecting equipment  
2. Prevent the development of localised bacterial infections, such as abscesses, by providing 
sterile injecting equipment  
3. Prevent overdose through information on how to recognise it and what to do should it occur  
4. Prevent the move from smoking to injecting and lower the incidence of injecting through the 
provision of tinfoil  
5. Facilitate sterile and safe injecting through the provision of equipment, information and safer 
injecting training  
6. Provide information on the importance and availability of HIV and Hepatitis C testing  
7. Manage localised bacterial infections through referral for the provision of sterile dressing and 
medication (where necessary)  
8. Provide information to the drug user in respect of relevant social and addiction services and 
refer the drug user to same when appropriate  
 
The PNEX Programme provides sterile injecting equipment, condoms and facilitates the return 
of used equipment in order to prevent the spread of BBVs. Pharmacies also refer individuals to 
drug treatment ; BBV/testing ; Hepatitis B vaccination and homeless services.  Data submitted 
by pharmacies to the PNEX Programme indicates that low numbers of referrals were made in 
2013, suggesting that increased referrals are needed not just for specialist groups but for all 
clients accessing pharmacy needle exchanges.  
 
The research was undertaken as part of the national evaluation of the three year pilot stage of 
the PNEX in 2014. The PNEX at the time of the evaluation reported 26,196 needle exchange 
transactions, with approximately 600-1100 unique individuals attending each month, of which 
70% were males (mean age 32 years) and 30% females (mean age 30 years). In the vast 
majority of transactions the service user injected opioids. In small numbers of transactions only, 
service users were recorded as injecting anabolic steroids, tanning agents and cocaine/ 
amphetamines. Specific referrals to treatment services (n=436), BBV testing (n=402) and 
Hepatitis B vaccinations (n=262), and an additional 74 referrals to other unspecified services 
were recorded.  We report here on the qualitative element of the evaluation conducted with 
pharmacists in order to understand and illustrate pharmacist experiences of toward providing 
needle exchange services.  
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Material and Methods 
The national evaluation of the three year pilot stage of the PNEX was conducted in 2014. This 
involved a mixed method approach using a national survey and interviews conducted with 
pharmacists, and service users. All pharmacies participating in the PNEX programme in April 
2014 were eligible to take part in the evaluation. The aims of the evaluation were to:  
1. To understand client and stakeholder satisfaction with needle exchange and attitudes 
towards and experiences of, these services. 
2. To provide data relating to safer injecting, safer sexual behaviour and the prevalence of 
blood borne viruses that can be used in comparison to international literature and can 
be measured against in future evaluations. 
3. To provide recommendations regarding the development and delivery of services and 
policy. 
The Irish Pharmacy Union and the PNEX Programme contacted pharmacies participating in the 
programme to inform them of the purpose of the project and their support for it. The research 
team contacted eligible pharmacies participating in the PNEX programme via email with follow-
up telephone call, and asked pharmacists to complete the online survey, participate in an 
interview with a member of the research team and encourage service users to take part in the 
research through interviews. Non-responding pharmacies were contacted by telephone on a 
minimum of two further occasions and asked to participate in the study.  
 
In terms of the qualitative element of the research, of the 107 eligible pharmacies participating 
in the PNEX programme, 30 pharmacists (9 males and 21 females) located across Ireland 
agreed to partake in the interviews. Reasons for not participating included refusal, the NSP 
service was not yet operational or had ceased to operate and that NSP was operating but no 
clients had attended the service at the time of the evaluation.  
 
Based on the aims 1 and 3 of the evaluation, consultation with extant literature and several 
meetings of the research team, a semi-structured interview guide was designed to examine 
pharmacist perceptions and experiences of delivering needle exchange including client profile, 
equipment provision, service provision, service successes, barriers towards service delivery and 
data monitoring processes.  Interviews were conducted by author 2, a trained researcher. 
Ethical approval for the evaluation protocol was granted by Liverpool John Moores University, 
United Kingdom. Prior to agreeing a date and time for conducting interviews, participants were 
provided via email with information about the research objectives, informed that they would be 
recorded, and also their right to withdraw from the research at any time. Written consent was 
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given by all participants who partook in face to face interviews, with verbal consent provided 
via telephone.  Interviews were conducted via telephone (n=17) and face to face (n=13), lasted 
45-90 minutes and audio-recorded with permission.  
 
Audio files were transcribed with the data hand coded with analysis with support from QSR 
NVivo 10 using the Empirical Phenomenological Psychological (EPP) five step method.31 This 
method emphasizes an open, non-judgmental and bias free attitude to interpretation of data, 
with respect to the participants and is underpinned by the facilitation of the meaning of lived 
phenomena,31,32  in this instance describing the experiences of pharmacists in providing needle 
exchange and interacting with service users. The steps involved the following analytical process 
conducted by author 4, and in consultation with author 2. The data file was read three times so 
as to familiarize, identify psychological phenomena and achieve an overview of the codeine 
misuse phenomenon in an unbiased and open manner, and in the absence of any specific 
hypothesis. Theoretical reflection was withheld at this step. The text was then divided into 
smaller meaning units (MU), without regard to syntax, included whole paragraphs to single 
words, and each time a new meaning, focus or topic was introduced. All MUs were subsequently 
transformed from the participants wording and restated in order to present significant and 
implicit meanings in objectivised terms. In order to obtain interpretative validity 32 considerable 
efforts were made to ensure respect of the participants’ experience. The restated MUs were 
categorised by repeated consultation with the raw data, scrutinizing that the category itself was 
maintained, the understanding of what the phenomenon is (noema) and how it is expressed 
(noesis) and by considering specific characteristics and similarities in participant experiences of 
NSP provision. The generated categories were then part of an abstraction process to create 
more general and overarching themes through the patterns identified within related categories. 
 
Results 
Seven descriptive themes emerged from the analysis, and we present them as follows with 
illustrative quotes.  
Operation of the Needle Exchange  
In general the needle exchange service was observed by all participants to be working well in 
their pharmacy and creating useful points of regular and transient contact with PWID. The 
service was described as quick and efficient with minimal impact on the running of other 
pharmacy activities.  
‘We are a really busy pharmacy and I did worry about if they have to wait when they 
come in and would that be a problem, but it’s actually been really well. I think it’s been 
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going a lot better than expected and we have had a lot more exchanges than expected 
as well.’ Participant #11 
The needle exchange as point of contact in providing clean injecting equipment was deemed as 
important by all participants in promoting safe injecting practices as well as the dissemination 
of harm reduction and health related information, and provision of medical support and 
treatment referral from the community pharmacy. One participant observed; 
‘I think the opportunity I suppose to have engagement with people that might not 
otherwise get opportunities to engage with healthcare professionals, it’s satisfying. 
Participant #17 
Main street and city centre pharmacies were viewed by the majority to be better locations for 
providing needle exchange services, due to lack of transport for many service users. Some 
pharmacy needle exchanges also dispensed methadone to service users. In terms of operation of 
the needle exchange in the pharmacy, practical considerations included the need for pharmacy 
staff to be vaccinated against Hepatitis B, and the regular collecting of bins containing used 
needles.  
 
Service User Awareness and Uptake of the Service 
Participants described service user profiles as ranging from young drug users to older, long-
term PWID. Age was viewed as difficult to determine at times, but most dates of birth supplied 
placed service users ranged between mid-teens to mid-forties in age. Some service users were 
described by participants as engaging on behalf of others. In general, male service users were 
perceived as more common than female. Poly substance use and issues with homelessness were 
reported by all participants.  Some service users were described as not accessing other services, 
with a minority waiting to access treatment. Relapse instances were described as common 
amongst those receiving treatment.  
‘Most are quite young. Living in hostels or some sort of subsidised housing Most of 
them fit into that category. They seem to have no social supports only more of that 
peer group.  We have very few maybe over 40, 1 or 2. They don’t live that long or they 
come off the program before that age.  Quite a few foreigners, Polish, Lithuanian, 
European origin. More male than female, well more males seem to make the contact 
as opposed to the females. The females tend to be better to return them.’ Participant 
#2 
 
Uptake of the needle exchange service appeared to be dependent on heroin availability in some 
of the community pharmacies. Half of participants commented on the need for their pharmacy 
to increase service user uptake. One participant observed; 
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 ‘It’s ok it’s just that we don’t have an awful lot of clients, we’ve tried to address that 
but obviously you can’t make people come to a place or location if they don’t want to.’ 
Participant #24 
Increasing uptake was reported in other sites, but with no change in gender profiles. Recent 
changes in service user profile centred on participant observations of increasingly younger 
users, and members of the Irish Traveller (Gypsy) Community requesting needles for the 
injecting of melanotan, a synthetic tanning peptide hormone and anabolic androgenic steroids. 
A rise in uptake from migrant groups from Eastern Europe was observed by some pharmacy 
sites. Word of mouth, for the most part, was viewed as most likely to alert PWID to provision of 
the service, with several comments made by participants around the lack of familiarity of users 
with the needle exchange logo visible at pharmacy entry point. Access and continued uptake by 
service users was perceived to be facilitated by speedy transactions, provision of private entry 
in some sites, and exchanges with staff occurring in private consultation rooms. 
‘Anybody who comes in wants to get out as quick as possible, you know they don’t 
want to be hanging about they don’t want anybody to see them, so fine. Now we 
haven’t had really much hassle with anybody, everyone is fine.’ Participant #4  
Participant experiences with service users were generally very positive. The majority of service 
users accessed the needle exchange alone. For the most part, service users were viewed to be 
polite, mannerly and abiding by the rules of the shop. This was viewed by participants to be 
grounded in verbal instruction and ground rules for acceptable behaviour provided by the 
pharmacist. Some minor incidents of visible intoxication and shoplifting were reported. 
‘Overall they’re usually quite friendly and appreciative. Sometime they’re a bit 
agitated or in a rush, you know you can understand that, or if they’re having a bad 
week or whatever, but like I say we’ve only had one or two problems.’  Participant #23 
There was evidence of residual concerns and some continued mistrust of PWID. This can be 
seen in the comments: 
 ‘because they have a tendency to steal, you tend to deal with them maybe quicker 
than you might want to ordinarily’ where the participants have concerns about the 
honesty of the clients, the impact of multiple NSP clients on other 
customers’.Participant#18 
A further example can be seen in the case of a pharmacist who felt obliged to specifically ask the 
staff if they have ‘had any incidents with clients’, despite the lack of evidence to suggest any risk. 
   
The Needle Exchange Transaction 
The needle exchange transaction itself was viewed as efficient, but in some instances hampered 
by poor dialogue and opportunity for engagement between pharmacist and service user, and 
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low return rates of used sharps. Some participants reported never receiving used packs in 
return for new equipment but continued to emphasise the need to advise service users on the 
safe disposal of used needles and equipment. Such efforts to encourage the needle exchange 
transaction was described by participants as contributing to increased rates of return overtime. 
The more middle class user (as perceived by participants) were deemed to be more responsible 
in returning used packs. 
‘It’s a prompt service, the very minute they come it’s there, they are dealt with. I go 
through the pack with all the new customers that come in and I ask them do they have 
any empties so I think the service is fine, you know I’m not judgemental to them I just 
wish they’d bring back the packs, like they’re getting it for free you know.’ Participant 
#5 
Some comments were made that the needle exchange transactions could be improved in terms 
of level of engagement with the user. The exchange itself was described by the majority as a 
quick process, with service users appearing anxious to leave the site. Lack of interaction was 
generally due to service user reluctance to engage, and pharmacist lack of time caused by busy 
retail and dispensing environments. Some participants described visible service user 
impatience in waiting their turn for the needle exchange transaction. Possible reasons for this 
included opiate craving and the stigma of IDU.  
‘We do have a ‘1 in’ policy. So that you’re not having a string of them coming in at 
once where it’s too overpowering. Participant #3 
 
Confidentiality and discretion on the part of pharmacists engaged in the needle exchange 
transaction was viewed as important in ensuring continued uptake of the service. Private 
consultation rooms were useful in promoting a confidential service. Communication between 
adjunct pharmacy staff (dispensing technicians and point of sale) was viewed as important in 
monitoring the service itself and the experience of staff. One participant observed; 
‘The girls [staff] are happy with the service. I do keep a check with them ask like “have 
you any problems, is there anything more I can do, is there anything more we need to 
provide for our clients or any incidences where you have had an incident with a 
client”.’ Participant #3 
Service user information was recorded as per the protocols of providing the needle exchange 
service. Some participants observed that they were unsure whether the exchange was for the 
service user themselves, particularly when attempting to access needle exchange without 
‘empties’, and comments were made around confirmation of identity and frequent supply of 
false names. Improvements in data capture and submission was viewed by one participant as 
warranting a specific electronic system.   
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‘I say to them all the time but like we never get any empties back here, never ever. But 
they do give me the information, their names and date of births but sure they could be 
anyone’. Participant #5  
 
The Needle Exchange Packs 
Many positive comments were made around the contents of the provided safe injecting kits. 
Pack size options were described by the majority of participants as optimising efficiency and 
discretion for the user, and that service users generally chose to take the ‘three needle’ pack.  
Some comments were made around encouraging use of 10 packs, in order to reduce sharing 
activity. Other participants disagreed with 10 packs for wastage reasons. One participant 
observed; 
 ‘A lot of times they prefer the 3 packs, I think its size, portability and the lads like to 
stick it in their pocket rather than carry it in the pharmacy bag, they think people 
know what’s in the bag” Participant #23 
 
Many participants observed that service users reported to them that needles and syringes 
provided are not the right size or right volume, with many describing them as too small. Some 
service users as a consequence were described as purchasing diabetic needles. Some requests 
for longer needles for groin injecting were also reported. One participant observed; 
‘Well the kits are inflexible and we do get requests for alternatives in terms of needles 
and we only have a very inflexible set that we can give out. I think we are pharmacists 
after all we can dispense things up. So that would be something that could be better’ 
Participant #9 
Some participants observed the need for provided packs to provide more alcohol wipes, citric 
and alternative types of needles. Tourniquets are also viewed as warranting inclusion in the 
pack. Three packs do not contain condoms, and this was queried by some service users. Most 
pharmacies reported providing the water separately, which was also viewed by some as 
warranting inclusion in the pack.  
‘Some people ask for extra citric with the smaller packs and we don’t have the citric on 
their own, they are all packed individually with the needles. Some people look for 
individual needles. We try and discourage that because we want them to take the box 
with them so they have something to put them into.’ Participant #2 
Other comments centred on advising service users to use the small black kit in the ‘three’ pack 
for disposal and storage of used needles. Service users in some instances weren’t aware that 
this can be used to store used needles. Having the sharps bin as separate to the provided 
needles was viewed as safer by some participants.  
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Relationships and Trust 
The development of a relationship based on ‘respect, empathy and harm reduction’ between 
service users and staff was viewed by all as important in increasing uptake in the needle 
exchange, and reducing unsafe injecting practices. First contact characterised by friendliness on 
the part of the pharmacist and frontline staff was viewed by many as vital in creating the initial 
steps of a relationship. Other comments centred on providing support in a friendly and non-
judgemental atmosphere.  
‘I do think that we do establish contact with them. I think it’s very important that first 
contact, that it’s not too aggressive and gets them to back off, that its open and 
friendly, and I think we do that well.’ Participant #2 
Use of private consultation rooms was viewed by many as important in relationship building 
and pharmacist assistance in dealing with service user health related queries. Despite these 
rooms, the needle exchange service itself was deemed by the majority as characterized by lack 
of interaction and the consequent speed of the process. This however was also observed to 
reduce the opportunity to engage in dialogue around injecting behaviours, health needs, 
concerns and requests for help. 
 ‘if they come in for anything like that because they have a tendency to steal, you tend 
to deal with them maybe quicker than you might want to ordinarily, But it can be 
done pretty quickly, in other words, sometimes a raised eyebrow will tell me what they 
want, so I can get ahead and give it to them.’ Participant #18 
Trust was viewed by participants as important in continued uptake of the service and was 
viewed as setting the foundation for volunteering of information from service users over time. 
Participants were very positive about providing the service in an efficient and discreet manner. 
Comments included;  
‘I think they can talk to the pharmacists and they trust them well, they kind of know 
them at this stage’ Participant #13 
 
Provision of Health Advice and Referrals 
Health advice, sexual health and wound care (advice and dressings) was offered in most sites, 
with at the minimum, advice leaflets in the provided packs given. General advice also centred on 
wetting the filter prior to injecting. The development of a series of health related questions and 
training on how to provide harm reduction advice around safe injecting, overdose prevention 
and overdose emergency actions were viewed by some as warranting development. Other 
needs include local referral information and provision of leafleting on HIV and hepatitis 
vaccination in the pharmacy. Comments included; 
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‘If they have obvious wounds on their hands we would assess them as they come in and 
say, oh look you need to go to see a doctor with that, that needs to be looked at, that’s 
infected – things like that.’ Participant #2 
‘I do try and get them to talk about their health or lack of, you know. Personal care 
also. Sometimes they’ll tell me and sometimes they’ll sit down and tell me their whole 
life story.’ Participant #27 
The majority of pharmacies engaged with local community drug services and methadone clinics, 
but with all participants observing the need for greater visibility of drug and alcohol services 
and referral routes. Some were aware of local treatment and detoxification services and 
referred service users to these when requested. Waiting times at these services were viewed as 
detrimental to service user treatment decision-making. Comments included; 
 ‘All we can do is recommend people to seek help and point them in directions. But 
we’ve no means of tracking whether they present or (not). We tend to see the same 
people the whole time, you know we might get a new person every so often and people 
disappear.’ Participant #20 
 
Training Needs and Support 
The majority of participants were satisfied with the needle exchange training provided. For the 
most part, continued training is needed on specific health related questioning and on where to 
refer service users to in terms of health, medical and treatment services. One participant 
observed; 
‘what I think I’d like is a bit more information about if they want to come off, the drug 
using and the needles and stuff like that. But I do think it’s a really good service, but 
there is room to improve.’ Participant #22 
Some participants described needing more information and specific training on the injecting 
needs for steroid and synthetic tanning (melanotan) injecting.  
‘Some people are using them for tan or steroids or something like that. Now I wouldn’t 
be familiar with anything like that so I wouldn’t know what to advise or how to 
advise.’ Participant #2 
 
Discussion 
We present here the qualitative findings gathered as part of the national evaluation of the PNEX 
pilot in Ireland.  Limitations of the study centre on the convenience sample aspects of 
participant recruitment, self-reporting of views and experiences, and the potential for 
researcher biases and idiosyncracies.  Validity of the study is however optimized by the 
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trustworthiness of the data in verification of extensive similarities across participant narratives, 
and horizontal consistency and vertical consistency in the interpretation of data.32 
 
Pharmacist experiences illustrated the positive nature of providing the service, and were 
encouraged by rising rates of uptake over time. Data recorded in the preceding year, indicated 
that numbers of people attending the needle exchange services in Irish pharmacies increased 
throughout 2013, suggesting that the programme was successfully engaging with PWID and 
increasing access to clean injecting equipment and contact with health professionals. The 
provision of pharmacy based needle exchanges in a variety of rural and urban settings is likely 
to be a key step towards achieving broad coverage across Ireland and reducing the risk of BBV 
transmission in Ireland. Of note is that pharmacists in their capacity as health providers are 
more likely to provide harm reduction services if their communities demand them.1,16-19,33-34 
 
Pharmacist experiences illustrated the positive nature of providing needle exchange services In 
contrast, findings elsewhere have illustrated more negative views, where some pharmacists 
have disclosed negative attitudes towards PWID and although attitudes towards the provision 
of services in pharmacies for PWID have generally improved in recent years they are still 
mixed.35-37 Recent systematic reviews have underscored the general positive attitude to 
providing harm reduction advice in pharmacies, with common barriers centring on lack of time 
and specific training, fear of attracting difficult service users, insufficient remuneration, and 
difficulties in communicating with adjunct health providers.2  Of note for this pilot programme 
going forward, and building on the goodwill and positive attitude toward providing NSP, is that 
service user perceptions of negative staff attitudes and experiences of discrimination have been 
associated with increased risk of needle sharing activities38 and the impact of needle and 
syringe exchange services on BBV infection may be greater where clients engage in other health 
interventions in addition to needle exchange.39 Equally, the attitudes of pharmacy staff towards 
service provision may improve with training11,16,35 and with increased experience of providing 
services.14 Where the needle exchange is a new service within the pharmacy, it might be 
expected that attitudes and relationships with clients improve with familiarity.14,26  Tesoriero et 
al.15 reported no increase in crime or staff/customer discomfort following implementation of 
needle and syringe exchange despite initial concerns. Many of the comments by participating 
pharmacists were positive with regard to the provision of sterile injecting equipment and were 
largely supportive of the actual client group. However, there was evidence of residual concerns 
and some continued mistrust of PWID.  
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Low return rates of used sharps were reported and requests for particular syringes are similar 
to studies conducted elsewhere.1,40-42  The World Health Organisation43 and National Institute 
for Health and Care Excellence (NICE)23  emphasise that increasing the coverage of sterile 
injecting equipment to PWID, towards the goal of a sterile syringe and needle for every injection 
is of paramount importance., in the prevention of blood borne virus transmission. However, 
effective disposal systems for used equipment are vital for improving the safety of communities 
and tackling negative attitudes towards needle exchange programmes. The mixed views of 
pharmacy staff in this qualitative study on the best methods to encourage returns of used 
needles and equipment suggests that the provision of consistent information to pharmacy staff 
through training is required. Providing those using the needle exchange with advice and 
information on disposal and making it simple for them to make returns is likely to be beneficial. 
It is important to again consider the privacy of those clients who wish to safely dispose of their 
equipment in the pharmacy. With increased engagement between staff and clients in the 
pharmacy, it may be likely that rates of returns will improve.  
 
Despite the speed of the needle exchange transaction itself and restriction to one service user at 
a time, pharmacists in this Irish study voiced intentions to develop trusting relationships and 
opportunities to engage with service users within a confidential service. Relationships with 
needle exchange service users are paramount to continued uptake, increased reach to other 
PWID or those users at risk of injecting, and the referrals toward ancillary social, medical and 
treatment services.40,44,46  It is regrettable that pharmacy models in busy retail environments to 
a certain extent are restricted by time pressures and staff availability. Increased contact and 
engagement between staff and clients is likely to increase trust and improve relationships. It 
was reported that transactions were typically quick and, particularly with new clients, there 
was a reluctance to engage fully. Creating an environment where clients feel comfortable is 
therefore important to maximise the benefits of the service. Concerns about privacy and 
confidentiality have been identified as a barrier to the delivery of public health services in 
pharmacies37,47 including to PWID.48  Guidance for pharmacies in the United Kingdom states that 
service users and pharmacists should be able to sit down together and speak to each other 
without being overheard by other customers or staff. The provision of consultation rooms 
where clients can discuss their drug use and related health concerns with pharmacy staff may 
lead to increased uptake of services and improved relationships between staff and clients.   
 
Pharmacists in this Irish evaluation expressed needs in relation to specific harm reduction 
training, specific promotional leaflets to raise awareness in their communities, and the 
provision of ‘fit for purpose’ exchange packs particular to the needs of their service users. For 
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example, in some areas, emergent trends included the injecting use of performance and image 
enhancement drugs, as distinct from the traditional PWID. Specific service user and staff 
training needs therefore appeared to centre on injecting use of steroids and tanning injections. 
This client group are of particular significance to needle and syringe programmes as they now 
account for over half of all clients the United Kingdom,49 with increasing numbers also being 
reported in Australia50 while a recent meta-analysis indicated a global lifetime prevalence of 
3.3%. Perhaps of even greater concern, is the evidence from the United Kingdom relating to HIV. 
HIV prevalence levels of between 1.5% and 2% amongst those who inject anabolic steroids and 
associated drugs, the same level as people who inject heroin or crack cocaine.51-52 Hepatitis B 
and C were also identified in this population, together with concerning levels of localized 
infection and injury.53 Pharmacists required some training on where to refer to, and should over 
time nestle within an interagency approach to dealing with addiction in the community. 
 
The epidemiology, behavior and associated risks amongst PWID is dynamic in nature. There are 
indications that Ireland, like the United Kingdom, will experience increases in those injecting 
PIEDs, a widening pharmacopeia54 including anabolic steroids, growth hormones and tanning 
agents, together with an ever changing array of novel psychoactive substances.55 It is essential 
that the changing profile of injectors is acknowledged and appropriate training developed and 
delivered 
 
Conclusion 
Pharmacist experiences illustrated the positive nature of providing the needle exchange service, 
and highlighted needs to develop specific harm reduction training for pharmacists, implement 
appropriate strategies to raise awareness of the services with PWID provide injecting 
equipment to meet the specific needs of their diverse service users and ensure the development 
of trusting relationships and opportunities to engage within a confidential service. 
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Article Highlights 
• Community pharmacists can provide quality harm reduction support to drug users via 
needle and syringe programmes (NSP).  
• 30 interviews were conducted with pharmacists as part of the national evaluation of the 
Irish Pharmacy Needle Exchange (PNEX) programme.  
• Pharmacist experiences illustrated the positive nature of providing NSP although some 
concerns regarding the client group remain 
• Pharmacists highlighted needs to further develop harm reduction training for 
pharmacists. 
• There is a need for appropriate strategies to raise awareness and meet service user 
specific needs.  
 
